Advertisement

Author: Jakob Emerson

The nation's largest health insurers have signaled significant headwinds in recent months across their Medicare Advantage and Medicaid businesses as costs rise and the effect of redeterminations takes hold.

A former AstraZeneca executive is facing federal cyberstalking charges for allegedly sending violent threats to executives at CVS Health and Aetna following issues with personal claims reimbursements, according to a criminal complaint filed May 8 in a Delaware federal court.

A possible divestiture buyer has backed out of a deal with UnitedHealth Group and Amedisys that aimed to make a proposed acquisition of the home health company more palatable to regulators, the Capitol Forum reported May 31.

Blue Cross and Blue Shield of Kansas City is exiting the Medicare Advantage market at the end of 2024, citing increasing regulatory requirements and financial headwinds. 

Advertisement

In less than a month's time, a federal lawmaker warned weight loss drugs have the potential to bankrupt the healthcare system, and new research from Blue Cross Blue Shield found nearly six in 10 patients taking the drugs don't reach…

Members' satisfaction with their commercial health plans has improved since last year, but the divide between the highest and lowest performing plans is getting bigger, according to J.D. Power's annual Commercial Member Health Plan Study published May 29. 

Seven states have awarded new managed Medicaid contracts in 2024. Not every award process has been finalized and several organizations are suing over denied contracts.

Advertisement